{"count": 11, "results": [{"_id": "2442555", "pmid": 2442555, "title": "Long-term monotherapy with lisinopril in renovascular hypertension.", "journal": "J Cardiovasc Pharmacol", "authors": ["Fyhrquist F", "Grönhagen-Riska C", "Tikkanen I", "Junggren IL"], "date": "1987-01-01T00:00:00Z", "doi": "10.1097/00005344-198700003-00015", "meta_date_publication": "1987", "meta_volume": "9 Suppl 3", "meta_issue": "", "meta_pages": "S61-5", "score": 50099.76, "text_hl": "Long-term monotherapy with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ in @<m>DISEASE_Hypertension_Renovascular</m> @DISEASE_MESH:D006978 @@@renovascular hypertension@@@.", "citations": {"NLM": "Fyhrquist F, Grönhagen-Riska C, Tikkanen I, Junggren IL. Long-term monotherapy with lisinopril in renovascular hypertension. J Cardiovasc Pharmacol. 1987;9 Suppl 3():S61-5. PMID: 2442555", "BibTeX": "@article{2442555, title={Long-term monotherapy with lisinopril in renovascular hypertension.}, author={Fyhrquist F and Grönhagen-Riska C and Tikkanen I and Junggren IL}, journal={J Cardiovasc Pharmacol}, volume={9 Suppl 3}, pages={S61-5}}"}}, {"_id": "24937322", "pmid": 24937322, "title": "Chronic infusion of lisinopril into hypothalamic paraventricular nucleus modulates cytokines and attenuates oxidative stress in rostral ventrolateral medulla in hypertension.", "journal": "Toxicol Appl Pharmacol", "authors": ["Li HB", "Qin DN", "Ma L", "Miao YW", "Zhang DM", "Lu Y", "Song XA", "Zhu GQ", "Kang YM"], "date": "2014-09-01T00:00:00Z", "doi": "10.1016/j.taap.2014.06.004", "meta_date_publication": "2014 Sep 1", "meta_volume": "279", "meta_issue": "2", "meta_pages": "141-9", "score": 50077.86, "text_hl": "@<m>DISEASE_Hypertension_Renovascular</m> @DISEASE_MESH:D006978 @@@Renovascular hypertensive@@@ @SPECIES_10116 @@@rats@@@ received bilateral PVN infusion with @GENE_ACE @GENE_24310 @@@ACE@@@ inhibitor @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@LSP@@@, 10mug/h) or vehicle via osmotic minipump for 4weeks. ", "citations": {"NLM": "Li HB, Qin DN, Ma L, Miao YW, Zhang DM, Lu Y, Song XA, Zhu GQ, Kang YM. Chronic infusion of lisinopril into hypothalamic paraventricular nucleus modulates cytokines and attenuates oxidative stress in rostral ventrolateral medulla in hypertension. Toxicol Appl Pharmacol. 2014 Sep 1;279(2):141-9. PMID: 24937322", "BibTeX": "@article{24937322, title={Chronic infusion of lisinopril into hypothalamic paraventricular nucleus modulates cytokines and attenuates oxidative stress in rostral ventrolateral medulla in hypertension.}, author={Li HB and Qin DN and Ma L and Miao YW and Zhang DM and Lu Y and Song XA and Zhu GQ and Kang YM}, journal={Toxicol Appl Pharmacol}, volume={279}, number={2}, pages={141-9}}"}}, {"_id": "3033998", "pmid": 3033998, "title": "Antihypertensive and hormonal effects of lisinopril, a new angiotensin converting enzyme (ACE) inhibitor in patients with renovascular hypertension.", "journal": "Acta Med Scand Suppl", "authors": ["Karlberg BE", "Rosenqvist U"], "date": "1986-01-01T00:00:00Z", "doi": "10.1111/j.0954-6820.1986.tb08965.x", "meta_date_publication": "1986", "meta_volume": "714", "meta_issue": "", "meta_pages": "33-42", "score": 50076.87, "text_hl": "Antihypertensive and hormonal effects of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@, a new angiotensin converting enzyme (ACE) inhibitor in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Hypertension_Renovascular</m> @DISEASE_MESH:D006978 @@@renovascular hypertension@@@.", "citations": {"NLM": "Karlberg BE, Rosenqvist U. Antihypertensive and hormonal effects of lisinopril, a new angiotensin converting enzyme (ACE) inhibitor in patients with renovascular hypertension. Acta Med Scand Suppl. 1986;714():33-42. PMID: 3033998", "BibTeX": "@article{3033998, title={Antihypertensive and hormonal effects of lisinopril, a new angiotensin converting enzyme (ACE) inhibitor in patients with renovascular hypertension.}, author={Karlberg BE and Rosenqvist U}, journal={Acta Med Scand Suppl}, volume={714}, pages={33-42}}"}}, {"_id": "2839326", "pmid": 2839326, "title": "Lisinopril: a new angiotensin-converting enzyme inhibitor.", "journal": "Drug Intell Clin Pharm", "authors": ["Armayor GM", "Lopez LM"], "date": "1988-05-01T00:00:00Z", "doi": "10.1177/106002808802200501", "meta_date_publication": "1988 May", "meta_volume": "22", "meta_issue": "5", "meta_pages": "365-72", "score": 50076.152, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@: a new angiotensin-converting enzyme inhibitor.", "citations": {"NLM": "Armayor GM, Lopez LM. Lisinopril: a new angiotensin-converting enzyme inhibitor. Drug Intell Clin Pharm. 1988 May;22(5):365-72. PMID: 2839326", "BibTeX": "@article{2839326, title={Lisinopril: a new angiotensin-converting enzyme inhibitor.}, author={Armayor GM and Lopez LM}, journal={Drug Intell Clin Pharm}, volume={22}, number={5}, pages={365-72}}"}}, {"_id": "7796449", "pmid": 7796449, "title": "Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.", "journal": "Cardiovasc Res", "authors": ["Kabour A", "Henegar JR", "Devineni VR", "Janicki JS"], "date": "1995-04-01T00:00:00Z", "meta_date_publication": "1995 Apr", "meta_volume": "29", "meta_issue": "4", "meta_pages": "543-8", "score": 50072.547, "text_hl": "METHODS: Control @SPECIES_10116 @@@rats@@@ and @SPECIES_10116 @@@rats@@@ with either @<m>DISEASE_Hypertension_Renovascular</m> @DISEASE_MESH:D006978 @@@renovascular hypertension@@@ or continuous @GENE_AGT @GENE_24179 @@@angiotensin II@@@ infusion (150 ng.min-1) for 14 d were subdivided into nine groups as follows: unoperated and untreated controls (n = 5); untreated @<m>DISEASE_Hypertension_Renovascular</m> @DISEASE_MESH:D006978 @@@renovascular hypertension@@@ (n = 8); untreated @GENE_AGT @GENE_24179 @@@angiotensin II@@@ (n = 9); a @<m>DISEASE_Hypertension_Renovascular</m> @DISEASE_MESH:D006978 @@@renovascular hypertension@@@ group receiving one of the following doses of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ 20 (n = 8), 2.5 (n = 4), and 0.6 (n = 6) mg.kg-1.d-1; a @<m>DISEASE_Hypertension_Renovascular</m> @DISEASE_MESH:D006978 @@@renovascular hypertension@@@ group receiving @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ (7.5 mg.d-1, n = 4); and an @GENE_AGT @GENE_24179 @@@angiotensin II@@@ group receiving either the high dose of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (n = 6) or @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ (n = 4). ", "citations": {"NLM": "Kabour A, Henegar JR, Devineni VR, Janicki JS. Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat. Cardiovasc Res. 1995 Apr;29(4):543-8. PMID: 7796449", "BibTeX": "@article{7796449, title={Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat.}, author={Kabour A and Henegar JR and Devineni VR and Janicki JS}, journal={Cardiovasc Res}, volume={29}, number={4}, pages={543-8}}"}}, {"_id": "6089307", "pmid": 6089307, "title": "Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.", "journal": "Scand J Urol Nephrol Suppl", "authors": ["Karlberg BE", "Fyhrquist F", "Grönhagen-Riska C", "Tikkanen I", "Ohman KP"], "date": "1984-01-01T00:00:00Z", "meta_date_publication": "1984", "meta_volume": "79", "meta_issue": "", "meta_pages": "103-6", "score": 50069.74, "text_hl": "@CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@Enalapril@@@ and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ in @<m>DISEASE_Hypertension_Renovascular</m> @DISEASE_MESH:D006978 @@@renovascular hypertension@@@--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. ", "citations": {"NLM": "Karlberg BE, Fyhrquist F, Grönhagen-Riska C, Tikkanen I, Ohman KP. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report. Scand J Urol Nephrol Suppl. 1984;79():103-6. PMID: 6089307", "BibTeX": "@article{6089307, title={Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.}, author={Karlberg BE and Fyhrquist F and Grönhagen-Riska C and Tikkanen I and Ohman KP}, journal={Scand J Urol Nephrol Suppl}, volume={79}, pages={103-6}}"}}, {"_id": "27786014", "pmid": 27786014, "title": "Enalapril and Lisinopril in Renovascular Hypertension Antihypertensne and Hormonal Effects of Two New Angio-Tensin-Converting-Enzyme (ACE) Inhibitors.", "journal": "Scand J Urol Nephrol", "authors": ["Karlberg BE", "Fyhrquist F", "Grönhagen-Riska C", "Tikkanen I", "Öhman KP"], "date": "1984-07-01T00:00:00Z", "doi": "10.1080/00365599.1984.11783725", "meta_date_publication": "1984 Jul", "meta_volume": "18", "meta_issue": "sup79", "meta_pages": "103-106", "score": 50069.043, "text_hl": "@CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ (@CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@MK-421@@@) and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@MK-521@@@) in 22 @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Hypertension_Renovascular</m> @DISEASE_MESH:D006978 @@@renovascular hypertension@@@. ", "citations": {"NLM": "Karlberg BE, Fyhrquist F, Grönhagen-Riska C, Tikkanen I, Öhman KP. Enalapril and Lisinopril in Renovascular Hypertension Antihypertensne and Hormonal Effects of Two New Angio-Tensin-Converting-Enzyme (ACE) Inhibitors. Scand J Urol Nephrol. 1984 Jul;18(sup79):103-106. PMID: 27786014", "BibTeX": "@article{27786014, title={Enalapril and Lisinopril in Renovascular Hypertension Antihypertensne and Hormonal Effects of Two New Angio-Tensin-Converting-Enzyme (ACE) Inhibitors.}, author={Karlberg BE and Fyhrquist F and Grönhagen-Riska C and Tikkanen I and Öhman KP}, journal={Scand J Urol Nephrol}, volume={18}, number={sup79}, pages={103-106}}"}}, {"_id": "7536715", "pmid": 7536715, "title": "Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension.", "journal": "Hypertension", "authors": ["Nakamoto H", "Ferrario CM", "Fuller SB", "Robaczewski DL", "Winicov E", "Dean RH"], "date": "1995-04-01T00:00:00Z", "doi": "10.1161/01.hyp.25.4.796", "meta_date_publication": "1995 Apr", "meta_volume": "25", "meta_issue": "4 Pt 2", "meta_pages": "796-802", "score": 50063.75, "text_hl": "During the chronic phase of @<m>DISEASE_Hypertension_Renovascular</m> @DISEASE_MESH:D006978 @@@renovascular hypertension@@@, the fall in blood pressure produced by acute systemic injections of @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ or @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ was significantly reduced in @SPECIES_9615 @@@dogs@@@ given the @CHEMICAL_Nitric_Oxide @CHEMICAL_MESH:D009569 @@@nitric oxide@@@ inhibitor. ", "citations": {"NLM": "Nakamoto H, Ferrario CM, Fuller SB, Robaczewski DL, Winicov E, Dean RH. Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension. 1995 Apr;25(4 Pt 2):796-802. PMID: 7536715", "BibTeX": "@article{7536715, title={Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension.}, author={Nakamoto H and Ferrario CM and Fuller SB and Robaczewski DL and Winicov E and Dean RH}, journal={Hypertension}, volume={25}, number={4 Pt 2}, pages={796-802}}"}}, {"_id": "1576040", "pmid": 1576040, "title": "Angiotensin-converting enzyme inhibitors.", "journal": "AACN Clin Issues Crit Care Nurs", "authors": ["Kuhn M"], "date": "1992-05-01T00:00:00Z", "doi": "10.4037/15597768-1992-2017", "meta_date_publication": "1992 May", "meta_volume": "3", "meta_issue": "2", "meta_pages": "461-71", "score": 50062.777, "text_hl": "The angiotensin-converting enzyme (ACE) inhibitors available today include @CHEMICAL_Captopril @CHEMICAL_MESH:D002216 @@@captopril@@@ (@CHEMICAL_Captopril @CHEMICAL_MESH:D002216 @@@Capoten@@@), @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ (@CHEMICAL_Enalaprilat @CHEMICAL_MESH:D015773 @@@Vasotec@@@), enaloprilat (Vasotec IV), @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Prinivil@@@, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Zestril@@@), @CHEMICAL_benazepril @CHEMICAL_MESH:C044946 @@@benazepril@@@ (@CHEMICAL_benazepril @CHEMICAL_MESH:C044946 @@@Lotensin@@@), @CHEMICAL_Fosinopril @CHEMICAL_MESH:D017328 @@@fosinopril@@@ (@CHEMICAL_Fosinopril @CHEMICAL_MESH:D017328 @@@Monopril@@@), and @CHEMICAL_Ramipril @CHEMICAL_MESH:D017257 @@@ramipril@@@ (Atace). ", "citations": {"NLM": "Kuhn M. Angiotensin-converting enzyme inhibitors. AACN Clin Issues Crit Care Nurs. 1992 May;3(2):461-71. PMID: 1576040", "BibTeX": "@article{1576040, title={Angiotensin-converting enzyme inhibitors.}, author={Kuhn M}, journal={AACN Clin Issues Crit Care Nurs}, volume={3}, number={2}, pages={461-71}}"}}, {"_id": "1320565", "pmid": 1320565, "title": "Captopril administered every three hours in difficult-to-control hypertension.", "journal": "Chest", "authors": ["Vardan S", "Mookherjee S", "Smulyan H"], "date": "1992-07-01T00:00:00Z", "doi": "10.1378/chest.102.1.303", "meta_date_publication": "1992 Jul", "meta_volume": "102", "meta_issue": "1", "meta_pages": "303-4", "score": 50059.863, "text_hl": "Convenient maintenance therapy with @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (10 mg twice daily) has kept blood pressure under control for a year.", "citations": {"NLM": "Vardan S, Mookherjee S, Smulyan H. Captopril administered every three hours in difficult-to-control hypertension. Chest. 1992 Jul;102(1):303-4. PMID: 1320565", "BibTeX": "@article{1320565, title={Captopril administered every three hours in difficult-to-control hypertension.}, author={Vardan S and Mookherjee S and Smulyan H}, journal={Chest}, volume={102}, number={1}, pages={303-4}}"}}]}